Back to User profile » Mr Patrick Lefebvre

Papers published by Mr Patrick Lefebvre:


Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis

Zhdanava M, Kachroo S, Shah A, Ding Z, Lefebvre P, Zhao R, Kerner C, Pilon D

Patient Preference and Adherence 2024, 18:809-820

Published Date: 10 April 2024

Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia

Lu X, Emond B, Morrison L, Kinkead F, Lefebvre P, Lafeuille MH, Khan W, Wu LH, Qureshi ZP, Jacobs R

Patient Preference and Adherence 2023, 17:2073-2084

Published Date: 23 August 2023

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey

Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D

Neuropsychiatric Disease and Treatment 2022, 18:2003-2019

Published Date: 7 September 2022

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B

Biologics: Targets and Therapy 2021, 15:1-15

Published Date: 6 January 2021

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

Chow W, Donga P, Côté-Sergent A, Rossi C, Lefebvre P, Lafeuille MH, Hardy H, Emond B

Patient Preference and Adherence 2020, 14:2315-2326

Published Date: 23 November 2020

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic

Pilon D, Joshi K, Tandon N, Lafeuille M, Kamstra RL, Emond B, Lefebvre P

Patient Preference and Adherence 2017, 11:619-629

Published Date: 23 March 2017